|
BMP2K expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.52779996934294E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.82429999995293E-06 |
| Normal-vs-Stage2 |
8.64180000004211E-07 |
| Normal-vs-Stage3 |
3.70029999974264E-08 |
| Normal-vs-Stage4 |
1.03539999907198E-08 |
| Stage1-vs-Stage2 |
5.642600E-01 |
| Stage1-vs-Stage3 |
2.930400E-01 |
| Stage1-vs-Stage4 |
6.804400E-02 |
| Stage2-vs-Stage3 |
7.869400E-01 |
| Stage2-vs-Stage4 |
2.961200E-01 |
| Stage3-vs-Stage4 |
3.660800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.59210000025578E-07 |
| Normal-vs-AfricanAmerican |
5.56860000000547E-07 |
| Normal-vs-Asian |
1.22620003040197E-09 |
| Caucasian-vs-AfricanAmerican |
2.969400E-01 |
| Caucasian-vs-Asian |
2.493600E-02 |
| AfricanAmerican-vs-Asian |
5.302000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.154210E-04 |
| Normal-vs-Female |
1.20780000445464E-08 |
| Male-vs-Female |
3.049400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.68910000000789E-05 |
| Normal-vs-Age(41-60Yrs) |
1.36800004657545E-09 |
| Normal-vs-Age(61-80Yrs) |
4.1785000015615E-08 |
| Normal-vs-Age(81-100Yrs) |
3.627700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.191800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.330040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.255600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.993600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.440200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.537200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.627560E-01 |
| Classical-VS-Follicular |
8.005900E-02 |
| Classical-VS-Other |
4.443600E-04 |
| Classical-VS-Normal |
5.99469999973401E-07 |
| Tall-VS-Follicular |
9.841600E-01 |
| Tall-VS-Other |
3.871600E-02 |
| Tall-VS-Normal |
3.49520000053616E-07 |
| Follicular-VS-Other |
2.118000E-02 |
| Follicular-VS-Normal |
2.90409996051011E-09 |
| Other-VS-Normal |
5.54590040557912E-10 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.46180000326623E-08 |
| Normal-vs-N1 |
1.04890000018898E-08 |
| N0-vs-N1 |
2.897600E-01 |
|
|
